Arrhythmia Latest News Archive
The American College of Cardiology, the American Heart Association, and the Heart Rhythm Society have released a guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay.
The currently available DOACS are at least as effective and safe as warfarin for patients with nonvalvular atrial fibrillation.
Over 1.1 million packages of test strips distributed from January 12, 2018 to October 29, 2018 are being recalled.
To investigate the risk of cardiovascular adverse effects associated with this antibiotic class, researchers conducted a systematic review, meta-analysis, and network meta-analysis using studies identified through a search of MEDLINE, EMBASE, and the Cochrane Library.
The KardiaBand allows patients to collect an electrocardiogram (ECG) reading using their Apple Watch.
New-onset atrial fibrillation developed after noncardiac surgery is associated with a long-term risk of thromboembolism.
Tocilizumab led to a marked normalization of corrected QT intervals in patients with rheumatoid arthritis.
There may be a relationship between traumatic life event stress and atrial fibrillation in women over the age of 45 years old.
The vulnerability is associated with using an internet connection to update software between the Medtronic CareLink and CareLink Encore Programmers (models 2090 and 29901) and the Medtronic Software Distribution Network (SDN).
Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.
Variations in published stroke rates for patients with AF not receiving anticoagulants result in differences in the calculated net clinical benefit of anticoagulation.
Apple's newest Series 4 Watch now comes complete with new health features that American Heart Association President Ivor Benjamin, MD, has called "game changing."
Patients implanted with leadless pacemakers had fewer complications in both short- and midterm events compared with patients who received transvenous pacemakers.
Healthy nonmenopausal women taking oral contraceptives exhibited biomarkers for drug-induced torsade de pointes.
Esmolol Hydrochloride in Sodium Chloride Injection 2500mg/250 mL (10mg/mL) Single-Dose Plastic Bag and 2000mg/100mL (20mg/mL) Single-Dose Plastic Bag, a generic version of Brevibloc (Baxter) now available from Mylan.
The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.
The use of a supraglottic airway device compared with tracheal intubation did not result in a favorable functional outcome in patients with out-of-hospital cardiac arrest.
The KardiaK Platform works through a deep neural network trained to detect hyperkalemia based on data from electrocardiograms (ECG) similar to those captured by the Company's KardiaMobile and KardiaBand devices.
Patients aged 21 years with Wolff-Parkinson White syndrome are at high risk for a life-threatening event.
The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.
Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.
Clinical outcomes in atrial fibrillation vs atrial flutter differ in terms of ischemic stroke, heart failure hospitalizations, and all-cause mortality.
The most common findings in patients with Chagas cardiomyopathy include cardiac rhythm abnormalities, myocardial abnormalities, aneurysms, and thromboembolism.
Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.
Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.
Studies comparing MMT to buprenorphine maintenance treatment (BMT) over 5-years found buprenorphine to be a safer drug for opioid maintenance treatment as it had no significant effect on QT prolongation.
Individuals with more frequent nighttime awakening exhibited a higher risk for atrial fibrillation.
Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.
After a Department of Justice investigation, the rate of noncompliant implantable cardioverter-defibrillator use significantly decreased in the hospital setting.
Using a continuous ECG monitoring patch at home in patients at high risk for atrial fibrillation resulted in higher diagnosis rates, more anticoagulation initiation, and increased healthcare resource utilization.
Cesium chloride is not approved by the FDA to treat cancer or any other disease.
Atropine is a muscarinic antagonist and is indicated for temporary blockage of severe or life threatening muscarinic effects.
Patients with leadless cardiac pacemakers experienced fewer short-term and midterm complications, but more pericardial effusions than patients with standard transvenous pacemakers.
Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
Acute myocarditis complicated by left ventricular systolic dysfunction confers a higher risk for cardiac death and heart transplant compared with uncomplicated acute myocarditis.
Arrhythmia was a significant predictor of mortality in adult patients with congenital heart disease and pulmonary arterial hypertension.
A greater burden of atrial fibrillation or flutter in patients with paroxysmal atrial fibrillation was associated with a higher risk for stroke when not taking anticoagulants.
Researchers conducted a systemic review and met-analysis to examine the effect of type 2 diabetes on heart rate variability.
Lokelma is a non-absorbed zirconium silicate that preferentially captures potassium in exchange for hydrogen and sodium.
The International Liaison Committee on Resuscitation noted knowledge gaps in the categories of automated external defibrillators, cardiopulmonary resuscitation quality, advanced life support, and pediatric life support.
In patients with coronary heart disease and a history of myocardial infarction, many sudden, arrhythmic deaths had a clinical history of angina.
Andexxa, a recombinant modified human Factor Xa (FXa) protein, was approved under the FDA's Accelerated Approval pathway.
Peripheral artery disease with a borderline ankle-branchial index appears not to increase the risk for atrial fibrillation.
Anxiety may increase the risk for ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation.
Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.
Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.
A meta-analysis sought to determine the effect of influenza vaccination on cardiac-related mortality in patients with heart failure.
Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.
Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.
The HeartStart MRx defibrillator may fail at any time, including during repeated shocks while in AED mode.
Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.
The International Liaison Committee on Resuscitation released an updated consensus on cardiopulmonary resuscitation and emergency cardiovascular care.
Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.
Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation
In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.
Guidelines for Point-of-Care Use of Transesophageal Echocardiography in Cardiac Arrest Resuscitation
Transesophageal echocardiography offers many clinical benefits in patients with cardiac arrest compared with transthoracic echocardiography.
Patients who had short-run atrial tachyarrhythmia experienced significantly higher rates of stroke compared with patients who did not have short-run atrial tachyarrhythmia.
Patients with atrial fibrillation who are treated with oral anticoagulants often experience renal function decline.
No significant association was found between atrial fibrillation risk and leukocyte telomere length.
FDA has cleared the KardiaBand device to recordtheir EKG to detect normal heart rhythms and atrial fibrillation.
Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement
A new consensus statement provides updated guidelines for antithrombotic therapy in patients with atrial fibrillation associated with valvular heart disease.
The American College of Cardiology released an expert consensus decision pathway intended to guide clinicians in managing bleeding in patients treated with anticoagulation.
Compared with warfarin, direct oral anticoagulants lowered the risk for stroke and death risk in patients with incident atrial fibrillation.
Persistent atrial fibrillation is associated with a higher risk for mortality compared with paroxysmal atrial fibrillation.
Continuous monitoring with an insertable cardiac monitor was found to be superior at detecting subclinical atrial fibrillation compared with a Holter monitor.
The 10 mg dose of rivaroxaban substantially lowered the risk for recurrent venous thromboembolism.
A recall has been issued for one lot of amiodarone due to possible particulate matter introduced into the solution.
A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.
Change in inducibility status after pulmonary vein isolation is not associated with long-term freedom from recurrent arrhythmia.
Patients with atrial fibrillation had improved late survival when treated with ablation-assisted Cox-Maze IV and cardiac surgery.
Risk prediction models to assess bleeding risk in patients with atrial fibrillation may be useful for optimizing treatment.
Although amiodarone and lidocaine were not proven to be efficacious in out-of-hospital cardiac arrest, researchers noted that the trend toward survival could suggest potential benefits.
Risk for poststroke cognitive impairment is increased by the presence of atrial fibrillation.
Classification of predominant obstructive sleep apnea in atrial fibrillation is affected by use of apneas vs hypopneas.
Patients who received synchronized left ventricular pacing with the AdaptivCRT had a lower risk of developing atrial fibrillation compared with patients who received conventional cardiac resynchronization therapy.
Daily short-term rhythm recordings may help diagnose atrial fibrillation in geriatric patients.
Women with atrial fibrillation and diabetes have higher rates for mortality and cardiovascular disease compared to men.
Patients diagnosed with new atrial fibrillation after ischemic stroke were more likely to have preexisting cardiovascular comorbidities such as hypertension, heart failure, and coronary artery disease.
Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.
Patients treated with zoledronic acid had a higher risk for atrial fibrillation and other arrhythmias as well as heart failure vs untreated patients.
Patients with type 1 diabetes have an increased risk for atrial fibrillation.
The FDA has granted clearance for a new non-invasive acoustic and electrocardiogram device for the detection of physiological and pathological heart murmurs.
A self-instructional kiosk at a US airport revealed considerable public interest in learning Hands-Only CPR.
Cardiology care in patients with newly diagnosed atrial fibrillation was associated with reductions in stroke and death.
The American Association for Thoracic Surgery recently released guidelines on the use of surgical ablation in atrial fibrillation.
Researchers presented new recommendations for handling in-flight cardiac arrest emergencies at the Euroanaesthesia 2017 meeting.
The American Association for Thoracic Surgery has developed evidence-based guidelines on the use of surgical ablation for atrial fibrillation.
Children aged 15-19 years appear to have the greatest risk of developing lone atrial fibrillation.
Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing
Long-detection programming improved survival, decreased the likelihood of hospitalization, and reduced therapy in patients with single-chamber ICDs.
Although stable sinus rhythm was achieved in some patients after LAA isolation, embolic stroke and LAA thrombus formation was still problematic.
The delayed start of anticoagulation treatment for atrial fibrillation has been linked to an increase risk for dementia.
Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.
All arrhythmic episodes were successfully converted, and no deaths were reported.
Magnetic resonance imaging appears to be safe in patients with implantable cardiac devices and abandoned leads.
The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.
Cardiac magnetic resonance was superior to transthoracic echocardiogram in identifying a pathologic substrate in patients with out-of-hospital cardiac arrest.
Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.
A systematic review of BMI and major adverse events in AF concluded that further evidence is necessary to clarify the relationship between obesity and AF.
Researchers found that use of NSAIDs like naproxen and ibuprofen were linked to increased out-of-hospital cardiac arrest risk.
Researchers conducted a meta-analysis to compare the safety and efficacy of sotalol vs amiodarone or beta-blockers to prevent supraventricular arrhythmias.
Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.
The Cardiology Advisor Articles
- Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis
- How Has the Medicaid Expansion Affected Patients Hospitalized With Acute MI?
- Macitentan Not Superior to Placebo for Improving Exercise Capacity in Eisenmenger Syndrome
- Association Between Statins and Depression Likely Mediated by Confounding
- Occupational Metal, Pesticide Exposure May Be Associated With Increased CVD Risk
- ASH Develops Practice Guidelines for Venous Thromboembolism
- Tetralogy of Fallot: Long-Term Outcomes After Surgical Repair
- Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis
- Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure
- Trends in Endocarditis Incidence After Implementation of 2007 AHA Recommendations
- Researchers Identify Golden Ratio Between Pulmonary Pressure Components in PAH
- FDA: Potential Increased Mortality With Paclitaxel-Coated Balloons, Stents for PAD
- Inhaled Dry Powder Formulation of Treprostinil Well Tolerated in PAH
- Elevated Myocardial T1 Associated With Increased Septal Angle in PAH
- Pulmonary Hypertension Intensive Care Options Depend on Treatment Goals